- Journal
- EUROPEAN UROLOGY FOCUS
- Année
- 2019
- Volume
- 5
- Numéro
- 2
- Pages
- 162-164
- Mois
- MAR
- DOI
- 10.1016/j.euf.2018.09.015
Abstract
Clinical trial data forms the foundation of how we treat men with metastatic prostate cancer who are initiating therapy. However, clinical trial data does not answer everything; hence, good clinical practice, pragmatism, and occasionally extrapolation drives how we manage these patients. Fortunately, multiple international guideline committees meet regularly and offer clinical guidance. In this mini-review, we focus on the United States National Comprehensive Cancer Network, European Society for Medical Oncology, and European Association of Urology (EAU) recommendations for the initial treatment of metastatic prostate cancer. (c) 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.